Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Crohn's & Colitis Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9338
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crohn’s & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn’s disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research services, clinical trial services and paediatric clinical trial services. CCF supports ongoing research initiatives and clinical studies to encourage cooperation among investigators, research centers, and other resources. The organization works in collaboration with healthcare providers and caregivers to deliver education, awareness and support services through patient-centric education and advocacy programs to patients suffering from inflammatory bowel diseases. It partners include European Federation of Crohn’s and Ulcerative Colitis Associations, International Organization of Inflammatory Bowel Disease (IOIBD) and International Ostomy Association. CCF is headquartered in New York, the US.

Crohn’s & Colitis Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Merger 12
Broad Foundations To Merge With Crohn’s & Colitis Foundation 12
Crohn’s & Colitis Foundation Inc – Key Employees 13
Crohn’s & Colitis Foundation Inc – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Oct 30, 2017: Crohn’s & Colitis Foundation Receives $5 Million to Fund Innovative Translational and Clinical IBD Research 15
Sep 11, 2017: Scientists Construct First Predictive Model of Inflammatory Bowel Disease 16
Other Significant Developments 17
Apr 11, 2018: The Crohn’s & Colitis Foundation Selects Diversigen as a Preferred Provider for Metagenomics and Microbiome Analysis Services 17
Feb 12, 2018: Crohn’s & Colitis Foundation Expands Patient-Powered Research Network 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn's & Colitis Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Broad Foundations To Merge With Crohn's & Colitis Foundation 12
Crohn's & Colitis Foundation Inc, Key Employees 13

List of Figures
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Physio-Control Inc:医療機器:M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務情報
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Guadalupe Valley Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Guadalupe Valley Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Suzano SA (SUZB5):企業の財務・戦略的SWOT分析
    Suzano SA (SUZB5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PsychoGenics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PsychoGenics Inc (PsychoGenics) is a preclinical contract research organization that offers treatment for CNS and orphan disorders.The company’s capabilities include electrophysiology, behavioral testing, translational EEG, molecular biology, quantitative histology and microdialysis. Its pro …
  • Mediq NV:企業の戦略的SWOT分析
    Mediq NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Pt Indofood Sukses Makmur Tbk:企業の戦略・SWOT・財務分析
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Epizyme Inc (EPZM):製薬・医療:M&Aディール及び事業提携情報
    Summary Epizyme, Inc. (Epizyme) is a biopharmaceutical company that develops novel epigenetic therapies for the treatment of cancer and other disorders. The company discovers and develops small molecule inhibitors of a class of enzymes, namely, histone methyl transferases (HMTs) and other chromatin …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Owens & Minor Inc (OMI):医療機器:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …
  • Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Antaros Medical AB (Antaros Medical) is a drug development and technology company that offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The company's services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 tri …
  • Verisante Technology Inc (VRS)-医療機器分野:企業M&A・提携分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • InvitroCue Ltd (IVQ):製薬・医療:M&Aディール及び事業提携情報
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image a …
  • Assore Limited:企業の戦略・SWOT・財務分析
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Surface Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Surface Oncology Inc (Surface Oncology) is a biopharmaceutical company that develops novel cancer immunotherapies for the treatment of cancer. The company develops treatments in which the immune system can be harnessed to fight cancer. It conducts pre-clinical study through new approaches to …
  • Alcazar Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary Alcazar Energy Ltd (Alcazar Energy) is a renewable energy company that acquires, develops and operates power generation projects using solar photovoltaic (PV) and onshore wind technologies. The company offers services such as business development, asset management, investment and financing, …
  • Grupo Posadas Sab De Cv
    Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report Summary Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆